In vivo pharmacodynamic modeling for drug discovery

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The use of animal infections models to assess antimicrobial efficacy is hardly a novel science. This practice dates back many decades, and, as might be expected, an exorbitant number of infection models in many different species have been employed over that time. Some of the more popular infection models include the following: thigh infection, lung infection, meningitis, sepsis, and urinary tract infection. Entire textbooks have been devoted to describing these models methodologically, and to do so again is not within the scope of this chapter. The purpose of this chapter, however, is to discuss some of the important concepts involved in developing any one of these models of infection to create meaningful data that can then be used to better characterize antimicrobials pharmacodynamically and ultimately to understand how these findings can translate to the clinic.

Cite

CITATION STYLE

APA

Crandon, J. L., & Nicolau, D. P. (2014). In vivo pharmacodynamic modeling for drug discovery. In Antibiotic Discovery and Development (pp. 1035–1054). Springer US. https://doi.org/10.1007/978-1-4614-1400-1_34

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free